Cargando…
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3
Patient: Female, 40 Final Diagnosis: Autoimmune polyendocrine syndrome type 3 Symptoms: Thirst • polyuria • weight-loss Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND: Patients with type 1 diabetes mellitus,...
Autores principales: | Gobaru, Mizuki, Ashida, Kenji, Yoshinobu, Satoko, Nagayama, Ayako, Kabashima, Masaharu, Iwata, Shimpei, Hasuzawa, Nao, Tsuruta, Munehisa, Wada, Nobuhiko, Nakayama, Hitomi, Motomura, Seiichi, Tajiri, Yuji, Nomura, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878962/ https://www.ncbi.nlm.nih.gov/pubmed/31745069 http://dx.doi.org/10.12659/AJCR.918996 |
Ejemplares similares
-
Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report
por: Nagayama, Ayako, et al.
Publicado: (2019) -
Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use
por: Goto, Yuka, et al.
Publicado: (2020) -
Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
por: Matsuo, Yuko, et al.
Publicado: (2023) -
Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment
por: Shikata, Masato, et al.
Publicado: (2020) -
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
por: Nagayama, Ayako, et al.
Publicado: (2021)